Key Hong Kong Stock Announcements: Senior Material and HJ SCIENCE-B Launch IPO Subscriptions Today

Stock News06-12

Key corporate developments are in focus today, with several companies announcing significant business moves, financial results, and capital market activities.

Senior Material (06067) has initiated its initial public offering subscription period from June 12 to June 17, planning a global offering of 149.5 million H shares.

HJ SCIENCE-B (06132) has also commenced its IPO subscription today, running until June 17, with plans to offer 13.6 million H shares globally.

Other notable corporate announcements include a strategic cooperation agreement in the field of Physical AI signed between Yujia Innovation and Le Dong Robotics. Le Dong Robotics, in turn, has signed a strategic cooperation agreement with Yujia Innovation to focus on deep collaboration in Physical AI and embodied intelligence. Furthermore, Le Dong Robotics announced that its global intelligent lawn mower robot brand, AnthBot, has appointed world-class goalkeeper Marc-André ter Stegen as its global brand ambassador.

Global New Material International announced that its research and development project for "Long-lasting Cosmetic-grade Synthetic Mica Powder" has passed the scientific and technological achievement evaluation conducted by the China Science and Technology Achievement Evaluation Center.

Federal Pharmaceutical has received implied approval for clinical trials of its new drug, TUL321 capsule, in China.

Boan Biotech has completed the authorization of its Dulaglutide Injection in the United States.

Tianchen Biotech-B announced that its Phase III clinical trial for LP-003 targeting seasonal allergic rhinitis has met its primary endpoint.

CStone Pharmaceuticals-B has initiated a global multi-center Phase I clinical trial for CS5007, an EGFR/HER3 bispecific antibody-drug conjugate.

Keleen Bio-Tech has received related payments from Yilian Biopharmaceutical according to a reached settlement agreement.

Yuexiu Transport Infrastructure plans to invest 261 million yuan to establish a new energy joint venture company.

AInnovation Group intends to sell its 33.5% stake in Haoya Qizhi (Shanghai) Intelligent Technology for 20.1 million yuan.

Federal Pharmaceutical plans to repurchase shares with a maximum amount of 200 million Hong Kong dollars.

Weilong Delicious plans to repurchase shares worth up to 200 million Hong Kong dollars.

HashKey Holdings plans to use no more than 100 million Hong Kong dollars for a share buyback.

Share Buybacks and Shareholding Changes

Several major companies conducted share repurchases on June 11. Tencent Holdings spent approximately 501 million Hong Kong dollars to repurchase 1.083 million shares. Xiaomi Group repurchased 7.8 million shares for about 202 million Hong Kong dollars.

WuXi AppTec repurchased approximately 1.4441 million shares for 176 million Hong Kong dollars. Tigermed Consulting repurchased about 3.0724 million A-shares for 122 million yuan. Li Auto repurchased around 2.2745 million shares for 121 million Hong Kong dollars.

Will Semiconductor Group spent 101 million yuan to repurchase about 1.1774 million A-shares. WuXi Biologics repurchased approximately 3.388 million shares for 99.8197 million Hong Kong dollars. J&T Express repurchased 9.44 million shares for 78.4502 million Hong Kong dollars.

Seres Group repurchased about 885,200 A-shares for 60.0015 million yuan. CRRC Times Electric spent approximately 60.3759 million Hong Kong dollars to repurchase 1.5218 million shares. Additionally, Bulten's executive director and controlling shareholder, Chen Fangming, increased his holdings by a total of 227,000 shares.

Operational Performance Updates

Chow Tai Fook reported a year-on-year increase of 14.7% in retail sales value for the first two months of the period.

Lygend Resources issued a positive profit alert, expecting its interim attributable net profit to be between approximately 2.25 billion yuan and 2.5 billion yuan, representing a year-on-year increase of about 57.3% to 74.8%.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment